English
Back
Download
Log in to access Online Inquiry
Back to the Top

Update

$Akoya Biosciences (AKYA.US)$ Reuters· 2 mins ago
Akoya Biosciences and Neracare Enter Into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
4271 Views
Comment
Sign in to post a comment
    5201
    Followers
    23
    Following
    75K
    Visitors
    Follow
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.